Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · November 04, 2024

Cost-Utility Analysis and Drug Pricing of Icodec vs Degludec for Patients With Type 2 Diabetes Receiving Basal Insulin

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Cost-utility analysis and drug pricing of once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes patients treated with basal insulin in China
Diabetes Obes Metab 2024 Sep 30;[EPub Ahead of Print], S Hu, S Wang, S Gu, C Qi, C Shi, G Fan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading